# Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos

> **NCT05511948** · PHASE2 · COMPLETED · sponsor: **DermBiont, Inc.** · enrollment: 75 (actual)

## Conditions studied

- Hyperpigmentation

## Interventions

- **DRUG:** DBI-102
- **DRUG:** Vehicle gel
- **DRUG:** Hydroquinone Cream

## Key facts

- **NCT ID:** NCT05511948
- **Lead sponsor:** DermBiont, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-18
- **Primary completion:** 2023-03-07
- **Final completion:** 2023-03-07
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2023-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05511948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05511948, "Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT05511948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*